Form 4: Immuneering Corp Executive Acquires Shares Through Employee Stock Purchase Plan

Mallory Morales, Chief Accounting Officer of Immuneering Corp, reports the acquisition of 4,458 shares of Class A Common Stock through the company's Employee Stock Purchase Plan at a price of $1.6235 per share.

Summary

• On September 15, 2024, Mallory Morales, the Chief Accounting Officer of Immuneering Corp, acquired 4,458 shares of Class A Common Stock.
• The acquisition was made through the Immuneering Corporation 2021 Employee Stock Purchase Plan (ESPP).
• The price per share was $1.6235.
• Following the transaction, Morales directly owns 12,736 shares of Class A Common Stock.
• The purchase was exempt under Rule 16b-3(c) of the Securities Exchange Act of 1934.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction related to executive compensation. The acquisition of shares by an executive is generally viewed as a positive sign, but it's not a major event.

Positives

• The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider transactions, specifically an executive's participation in the company's employee stock purchase plan. It's common for executives to acquire shares through such plans, and the disclosure is mandated by SEC regulations.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a company executive.

Key Dates